Clinical Trial Update: Combination Chemotherapy and Biological Therapy in Treating Patients With High-Risk Ewing's Sarcoma [Phase 2]

View source ↗

Summary

This update reports on a Phase 2 clinical trial evaluating a combination of chemotherapy and biological therapy for high-risk Ewing sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma | Phase 2 | Status: COMPLETED